CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,777,896 | +12.1% | 1,827,047 | -8.5% | 0.42% | +14.6% |
| Q2 2023 | $44,418,943 | +6.9% | 1,996,357 | +4.0% | 0.36% | +1.4% |
| Q1 2023 | $41,569,417 | +10.9% | 1,919,179 | +3.9% | 0.36% | +8.8% |
| Q4 2022 | $37,497,967 | +7.7% | 1,846,281 | +35.9% | 0.33% | -4.3% |
| Q3 2022 | $34,827,000 | +11.7% | 1,358,319 | +3.6% | 0.34% | +16.9% |
| Q2 2022 | $31,177,000 | +6.6% | 1,311,038 | +0.9% | 0.30% | +21.9% |
| Q1 2022 | $29,249,000 | +43.3% | 1,298,812 | +26.0% | 0.24% | +47.6% |
| Q4 2021 | $20,414,000 | -2.3% | 1,031,007 | -2.9% | 0.16% | -11.4% |
| Q3 2021 | $20,897,000 | +26.6% | 1,061,845 | +41.5% | 0.18% | +25.9% |
| Q2 2021 | $16,507,000 | -10.0% | 750,351 | -2.6% | 0.15% | -17.4% |
| Q1 2021 | $18,332,000 | +71.0% | 770,565 | +88.0% | 0.18% | +56.1% |
| Q4 2020 | $10,722,000 | – | 409,844 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |